ArticleFrontiers in sports and active living2025
Case Report: A 1-year progression of mediolateral gait instability during tandem walking in FXTAS.
Article in Frontiers in sports and active living, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a late-onset neurodegenerative disorder characterized by progressive motor dysfunction, including cerebellar ataxia and gait instability. Although tandem walking is a sensitive clinical marker of cerebellar dysfunction, its utility in tracking longitudinal motor decline in FXTAS remains unexplored and the trajectory of motor decline in FXTAS is not well characterized. Therefore, the purpose of this case report was to determine whether tandem walking performance deteriorates over a one-year period in an individual with FXTAS. A 68-year-old male with genetically confirmed FXTAS completed a 15-second tandem walking trial at baseline and again after one year. Kinematic data were collected using a Vicon motion capture system. Step width was calculated at each heel strike as the distance between the mediolateral position of the left and right heel markers. The mean step width considerably increased from baseline tandem walking of 45.21 ± 33.47 mm (SD) compared to the 1-year follow-up trial step width of 85.79 ± 15.80 mm (SD) indicating potential progressive mediolateral instability. This case report provides preliminary evidence that step width during tandem walking may be a sensitive marker of longitudinal motor decline in FXTAS and declines in gait stability can occur within one year. Larger studies with repeated measures and additional gait metrics are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.